Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,44 € ↑0,88 (1,88%)
2026-06-03
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionWealthspire Advisors, LLC
Latest Disclosed Ownership37,167 shares
Latest Disclosed Value $ 2,254,152
Wealthspire Advisors, LLC reports 8.49% decrease in ownership of BRM / Bristol-Myers Squibb Company

On May 1, 2026 - Wealthspire Advisors, LLC filed a 13F-HR form disclosing ownership of 37,167 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $1,948,294 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 40,617 shares of Bristol-Myers Squibb Company. This represents a change in shares of -8.49% during the quarter. The current value of the position is $1,763,017 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-01 2026-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 37,167 -3,450 -8.49 2,254 2.92 0.0177
2026-02-12 2025-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 40,617 14,898 57.93 2,191 88.96 0.0174
2025-11-14 2025-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 25,719 -32,443 -55.78 1,160 -56.95 0.0061
2025-08-11 2025-06-30 13F Bristol-Myers Squibb COM 110122108 58,162 -982 -1.66 2,692 -25.37 0.0151
2025-05-09 2025-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 59,144 30,465 106.23 3,607 122.38 0.0216
2025-02-04 2024-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 28,679 170 0.60 1,622 9.97 0.0161
2024-11-13 2024-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 28,509 1,286 4.72 1,475 30.53 0.0150
2024-08-08 2024-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 27,223 -1,464 -5.10 1,131 -27.33 0.0145
2024-05-06 2024-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 28,687 -6,714 -18.97 1,556 -14.37 0.0207
2024-02-07 2023-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 35,401 5,962 20.25 1,816 6.32 0.0258
2023-11-06 2023-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 29,439 4,878 19.86 1,709 8.79 0.0282
2023-08-01 2023-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 24,561 -2,522 -9.31 1,571 -16.36 0.0257
2023-05-09 2023-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 27,083 -4,398 -13.97 1,877 -17.13 0.0322
2023-02-14 2022-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 31,481 3,621 13.00 2,265 14.34 0.0412
2022-11-14 2022-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 27,860 5,123 22.53 1,981 13.14 0.0414
2022-08-09 2022-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 22,737 4,833 26.99 1,751 33.87 0.0366
2022-05-09 2022-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 17,904 -6,067 -25.31 1,308 -12.51 0.0294
2022-02-14 2021-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 23,971 1,765 7.95 1,495 13.77 0.0331
2021-11-15 2021-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 22,206 16,152 266.80 1,314 224.44 0.0273
2021-08-13 2021-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 6,054 -34,236 -84.97 405 -84.08 0.0106
2021-05-17 2021-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 40,290 8,700 27.54 2,544 29.80 0.0604
2021-02-16 2020-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 31,590 10,089 46.92 1,960 51.23 0.0583
2020-11-16 2020-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 21,501 3,611 20.18 1,296 23.19 0.0771
2020-08-14 2020-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 17,890 -18,515 -50.86 1,052 -48.15 0.0733
2020-05-12 2020-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 36,405 27,128 292.42 2,029 241.01 0.0851
2020-02-14 2019-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 9,277 4,360 88.67 595 138.96 0.0433
2019-11-12 2019-09-30 13F BRISTOL MYERS SQUIBB COM 110122108 4,917 4,917 249 0.0204
2019-05-07 2019-03-31 13F BRISTOL MYERS SQUIBB COM 110122108 0 -1,064 -100.00 0 -100.00
2019-02-14 2018-12-31 13F BRISTOL MYERS SQUIBB COM 110122108 1,064 1,064 55 0.0053
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.